Bicycle therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), today announced that on november 1, 2024, the compensation committee of the company's board of directors granted to twelve new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 56,700 ordinary shares. these awards were made under bicycle therapeutics' 2024 inducement plan and approved by the compensation committee as an inducement material to the employees enter.
NDAQ Ratings Summary
NDAQ Quant Ranking